ArticlePharmacoEconomics2007

Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia.

Theodore Darkow et al.PubMed ↗Publisher ↗

No numbers read from the abstract.